We’re giving shape to cell and gene therapy development every day, with 30+ years of biologics manufacturing and testing experience across all phases of clinical and commercial development. Our BioReliance® services offer the widest range of assays to fully characterize and analyze your therapy, giving you the confidence to deliver life-changing treatments to patients quickly and safely.   MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany.

Team Members


Martin De Cecco, Ph.D.

Global Scientific Lead, Product Characterization & Analytical Development

Kyle Reder-1

Kyle Reder

Segment Strategy Manager, Cell & Gene Therapy


Leyla Diaz, Ph.D.

Senior Technical Specialist, Field Technology Management